ISIN | LU1540960942 |
---|---|
Valor Number | 35006892 |
Bloomberg Global ID | |
Fund Name | HBM Global Healthcare Fund A USD Cap |
Fund Provider |
HBM Partners AG
Zug, Schweiz Phone: +41 43 888 71 71 E-Mail: investorrelations@hbmpartners.com Web: www.hbmpartners.com |
Fund Provider | HBM Partners AG |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) | FundPartner Solutions (Suisse) S.A. |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long-term capital gains, by pursuing a long/short strategy in the "healthcare" market. The goal is to generate a value trend that exceeds the performance of the SOFR (the “Benchmark”). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 260.44 USD | 21.11.2024 |
---|---|---|
Previous Price * | 258.78 USD | 20.11.2024 |
52 Week High * | 287.82 USD | 16.09.2024 |
52 Week Low * | 223.84 USD | 28.11.2023 |
NAV * | 260.44 USD | 21.11.2024 |
Issue Price * | 260.44 USD | 21.11.2024 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 18,707,216 | |
Unit/Share Assets *** | 2,119,788 | |
Trading Information SIX |
YTD Performance | +6.40% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD Performance (in CHF) | +12.11% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 month | -4.63% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -7.87% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -1.67% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +15.94% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +14.15% |
23.11.2022 - 21.11.2024
23.11.2022 21.11.2024 |
3 years | -2.06% |
24.11.2021 - 21.11.2024
24.11.2021 21.11.2024 |
5 years | +30.52% |
27.11.2019 - 21.11.2024
27.11.2019 21.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 7.94% | |
---|---|---|
UnitedHealth Group Inc | 7.53% | |
Novo Nordisk AS Class B | 6.06% | |
AbbVie Inc | 5.53% | |
Exact Sciences Corp | 5.34% | |
The Cooper Companies Inc | 5.26% | |
Stryker Corp | 4.05% | |
UCB SA | 4.04% | |
Intuitive Surgical Inc | 3.58% | |
Natera Inc | 3.56% | |
Last data update | 30.09.2024 |
TER | 0.0215% |
---|---|
TER date | 31.01.2018 |
Performance Fee *** | 15.00% |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 2.18% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |